Search research articles
Contact Us
Filters
Showing results (241-250 of 249) with videos related to
Page
of 25
Sort By:
You have reached the last page of results.
This site can display upto 249 results.
Psychiatric Services (Washington, D.C.)
|
March 2, 2016
Implementing the Collaborative Care Model as Part of a Countywide Initiative
Marcia Valenstein, Gregory W Dalack, Teague Simoncic, et al.
Cell Reports. Medicine
|
March 1, 2024
Follicular lymphoma B cells exhibit heterogeneous transcriptional states with associated somatic alterations and tumor microenvironments
Jordan E Krull, Kerstin Wenzl, Melissa A Hopper, et al.
Hematological Oncology
|
November 29, 2024
Molecular Features of Diffuse Large B-Cell Lymphoma Associated With Primary Treatment Resistance
Allison M Bock, Kerstin Wenzl, Joseph P Novak, et al.
Hematological Oncology
|
May 31, 2023
Molecular classification and identification of an aggressive signature in low-grade B-cell lymphomas
Melissa A Hopper, Kerstin Wenzl, Keenan T Hartert, et al.
Otolaryngology--Head and Neck Surgery : Official Journal of American Academy of Otolaryngology-Head and Neck Surgery
|
July 13, 2021
Accuracy and Reliability of 4D-CT and Flexible Laryngoscopy in Upper Airway Evaluation in Robin Sequence
Austin S Lam, Michael D Bindschadler, Kelly N Evans, et al.
Blood Cancer Journal
|
July 12, 2025
Integrated genomics with refined cell-of-origin subtyping distinguishes subtype-specific mechanisms of treatment resistance and relapse in diffuse large B-cell lymphoma
Janek S Walker, Kerstin Wenzl, Joseph P Novak, et al.
Blood Cancer Journal
|
October 9, 2024
DEK regulates B-cell proliferative capacity and is associated with aggressive disease in low-grade B-cell lymphomas
Melissa A Hopper, Abigail R Dropik, Janek S Walker, et al.
Medrxiv : the Preprint Server for Health Sciences
|
June 19, 2023
Multiomic Analysis Identifies a High-Risk Metabolic and TME Depleted Signature that Predicts Early Clinical Failure in DLBCL
Kerstin Wenzl, Matt Stokes, Joseph P Novak, et al.
Blood Cancer Journal
|
June 20, 2024
Multiomic analysis identifies a high-risk signature that predicts early clinical failure in DLBCL
Kerstin Wenzl, Matthew E Stokes, Joseph P Novak, et al.
Page
of 25
Search research articles
Search
Showing results (241-250 of 249) with videos related to
Sort By:
Page
of 25
You have reached the last page of results.
This site can display upto 249 results.
Psychiatric Services (Washington, D.C.)
|
March 2, 2016
Implementing the Collaborative Care Model as Part of a Countywide Initiative
Marcia Valenstein, Gregory W Dalack, Teague Simoncic, et al.
Cell Reports. Medicine
|
March 1, 2024
Follicular lymphoma B cells exhibit heterogeneous transcriptional states with associated somatic alterations and tumor microenvironments
Jordan E Krull, Kerstin Wenzl, Melissa A Hopper, et al.
Hematological Oncology
|
November 29, 2024
Molecular Features of Diffuse Large B-Cell Lymphoma Associated With Primary Treatment Resistance
Allison M Bock, Kerstin Wenzl, Joseph P Novak, et al.
Hematological Oncology
|
May 31, 2023
Molecular classification and identification of an aggressive signature in low-grade B-cell lymphomas
Melissa A Hopper, Kerstin Wenzl, Keenan T Hartert, et al.
Otolaryngology--Head and Neck Surgery : Official Journal of American Academy of Otolaryngology-Head and Neck Surgery
|
July 13, 2021
Accuracy and Reliability of 4D-CT and Flexible Laryngoscopy in Upper Airway Evaluation in Robin Sequence
Austin S Lam, Michael D Bindschadler, Kelly N Evans, et al.
Blood Cancer Journal
|
July 12, 2025
Integrated genomics with refined cell-of-origin subtyping distinguishes subtype-specific mechanisms of treatment resistance and relapse in diffuse large B-cell lymphoma
Janek S Walker, Kerstin Wenzl, Joseph P Novak, et al.
Blood Cancer Journal
|
October 9, 2024
DEK regulates B-cell proliferative capacity and is associated with aggressive disease in low-grade B-cell lymphomas
Melissa A Hopper, Abigail R Dropik, Janek S Walker, et al.
Medrxiv : the Preprint Server for Health Sciences
|
June 19, 2023
Multiomic Analysis Identifies a High-Risk Metabolic and TME Depleted Signature that Predicts Early Clinical Failure in DLBCL
Kerstin Wenzl, Matt Stokes, Joseph P Novak, et al.
Blood Cancer Journal
|
June 20, 2024
Multiomic analysis identifies a high-risk signature that predicts early clinical failure in DLBCL
Kerstin Wenzl, Matthew E Stokes, Joseph P Novak, et al.
Page
of 25